tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BEAM Stock Latest News

Beam Therapeutics initiated with a Hold at JonesResearch
The FlyBeam Therapeutics initiated with a Hold at JonesResearch
2d ago
BEAM
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
PremiumThe Fly
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
8d ago
BEAM
KRYS
Krystal Biotech price target raised to $220 from $204 at Stifel
PremiumThe Fly
Krystal Biotech price target raised to $220 from $204 at Stifel
8d ago
BEAM
KRYS
Beam Therapeutics price target raised to $69 from $66 at Stifel
PremiumThe Fly
Beam Therapeutics price target raised to $69 from $66 at Stifel
8d ago
BEAM
KRYS
Beam Therapeutics price target lowered to $31 from $33 at Barclays
PremiumThe Fly
Beam Therapeutics price target lowered to $31 from $33 at Barclays
1M ago
BEAM
Beam Therapeutics reports Q2 EPS ($1.11), consensus ($1.13)
PremiumThe FlyBeam Therapeutics reports Q2 EPS ($1.11), consensus ($1.13)
1M ago
BEAM
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
Premium
Press Releases
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
1M ago
BEAM
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
Premium
Stock Analysis & Ideas
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
2M ago
BEAM
CRSP
Beam Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Beam Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
BEAM
Cathie Wood’s ARK Investment buys 60K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 60K shares of Beam Therapeutics today
2M ago
BEAM
Cathie Wood’s ARK Investment buys 160K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 160K shares of Beam Therapeutics today
2M ago
BEAM
Beam Therapeutics selloff on CFO exit misplaced, says JPMorgan
PremiumThe Fly
Beam Therapeutics selloff on CFO exit misplaced, says JPMorgan
2M ago
BEAM
Beam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation
PremiumCompany AnnouncementsBeam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation
2M ago
8K
BEAM
Beam Therapeutics Announces Transition of Chief Financial Officer
Premium
Press Releases
Beam Therapeutics Announces Transition of Chief Financial Officer
2M ago
BEAM
Beam Therapeutics CFO Terry-Ann Burrell stepping down August 9
Premium
The Fly
Beam Therapeutics CFO Terry-Ann Burrell stepping down August 9
2M ago
BEAM
Fly Insider: RH, Chewy among this week’s notable insider trades
PremiumThe Fly
Fly Insider: RH, Chewy among this week’s notable insider trades
3M ago
NN
RH
Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
PremiumPress Releases
Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
3M ago
BEAM
Beam Therapeutics announces dosing of first patient with BEAM-302
PremiumThe Fly
Beam Therapeutics announces dosing of first patient with BEAM-302
3M ago
BEAM
Beam Therapeutics Stock (NASDAQ:BEAM): The Future of Gene Editing?
PremiumMarket News
Beam Therapeutics Stock (NASDAQ:BEAM): The Future of Gene Editing?
3M ago
PFE
APLS
Beam Therapeutics reports data from BEAM-101 trial
PremiumThe FlyBeam Therapeutics reports data from BEAM-101 trial
3M ago
BEAM
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
Premium
Press Releases
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
3M ago
BEAM
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
Premium
Press Releases
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
4M ago
BEAM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >